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FOCUS: Medication and Pregnancy
•		A	 growing	 number	 of	 pregnant	 women	 are	 facing	 chronic	 health	 issues	 such	 as	
diabetes,	hypertension	and	depression.		
•		Approximately	2/3	of	women	who	give	birth	in	the	U.S.	each	year	are	prescribed 
at least one medication other than a vitamin or mineral supplement during 
pregnancy.
•		There	is	a	severe	lack of clinical research	on	the	effects	of	medications	on	pregnant	
women	and	their	fetuses.		Only	a	dozen	medications	are	approved	by	the	FDA	for	use	
during	pregnancy;	all	are	for	gestation	or	birth	related	issues	such	as	anesthesia	or	
nausea.
•	 Healthcare providers are not always aware of which medications or dosages are 
safe	to	prescribe	during	pregnancy.	
•		Consumers	 often	 have	 misperceptions about the safety of vitamins, 
supplements or herbal remedies	 during	 pregnancy.	 	 In	 addition,	 many	
consumers do not report such use to their healthcare providers.  
•		Including	pregnant	women	in	clinical	trials	and	research	can	bring	a	host	of	ethical	
issues	and	decisions	about	fetal	protection,	maternal	risk,	and	even	paternal	consent.	
IPN’s Response
IPN	 is	 committed	 to	 providing	 timely,	 accurate	 information	 to	 health	 care	 professionals	 and	
consumers	about	best	practices	during	pregnancy.		
Among	these	efforts,	Indiana	Perinatal	Network…
•  Utilizes monthly e-bulletins and alerts to	 provide	 up-to-date	 communication	 on	 new	
advances in research
•  Convenes a Perinatal Mood Disorders Task Force to serve as a resource on medications that 
can	safely	be	used	to	treat	depression	during	pregnancy
•  Supports the State Breastfeeding Coordinator to stay current on medications that are safe 
for	women	to	take	while	breastfeeding
•  Educates providers about screening and treatment of substance use during pregnancy; 
in	addition	to	alcohol	and	tobacco	use,	pregnant	women	are	increasingly	abusing	prescription	
medications
•  Advocates for all healthcare providers	 to	adopt	a	 Learner’s	Stance	when	 interacting	with	
patients.  The goal is to help providers learn to communicate more clearly with patients 
about	their	pregnancies	and	to	approach	different	cultural	practices	and	health	behaviors	in	a	
respectful,	nonjudgmental	way.	
Medication Use During Pregnancy – What’s The Problem?
_________________________________________
Source: American Journal of Public Health
Clinical Update: Medication Use in Pregnant Women with Chronic Medical Conditions
Deborah	Zeitlin,	Pharm.D.  - Assistant Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences; Clinical 
Pharmacist, Indiana Clinic Family Medicine Center, Clarian Health
A	 recent	 preliminary	 report	 from	 the	 National	 Center	 for	
Health	 Statistics	 shows	 that	 the	 number	 of	 live	 births	 in	 the	
United	 States	 decreased	 in	 2008	 1--	 however,	 the	 rate	 of	 live	
births	 per	 1000	 women	 has	 increased	 in	 women	 40	 to	 49	
years.	 	Older	women	potentially	have	already	been	diagnosed	
and	 are	 actively	 being	 treated	 for	 chronic	medical	 conditions	
that	 include	 hypertension,	 asthma,	 diabetes	 and	 depression.	
Reports	have	shown	5%	of	pregnant	women	have	hypertension	
and	 the	 risk	 increases	 with	 age.2	 	 	 Asthma	 incidence	 ranges	
from	 4%	 to	 9%	 in	 pregnant	women.3	 	 	 Pre-existing	 diabetes	
is	prevalent	 in	12%	of	pregnant	women	in	the	United	States.4 
Finally,	depression	is	very	common	in	women	between	the	ages	
of	15	to	44	years.5
Chronic hypertension is more prevalent in women who are 
obese,	 African-American	 and	 older	 than	 35	 years.	 	 Untreated	
hypertension	 may	 cause	 cardiovascular	 or	 cerebrovascular	
events	in	the	mother,	but	the	fetus	is	at	risk	for	premature	birth,	
perinatal	mortality,	 interuterine	 growth	 restrictions,	 cesarean	
delivery,	 and	 superimposed	 preeclampsia.6  Medications are 
usually	 required	 in	 the	 third	 trimester	 or	 when	 the	 blood	
pressure	 is	 greater	 than	 160/105mmHg.	 	 Avoidance	 of	 ACE	
inhibitors	 and	 angiotensin-receptor	 blockers	 is	 necessary	
to prevent renal agenesis and malformed cardiovascular 
and central nervous systems.7	 	 	 Helpful	 non-pharmacologic	
recommendations	 include	 sodium	 restriction,	 appropriate	
vitamin	 supplementation,	 exercise,	 and	 avoidance	 of	 alcohol	
and	tobacco.8
Untreated	 asthma	 may	 increase	 the	 need	 for	 hospitalization	
or	 emergency	 room	 visits,	 oral	 corticosteroids,	 and	 cesarean	
delivery	as	well	as	 the	 risk	 for	preeclampsia,	premature	birth,	
and	low	birth	weight.6,9  Continuing current asthma medications 
is	safer	than	stopping	therapy,	and	budesonide	is	the	preferred	
inhaled corticosteroid.10	 	 	 Reinforcement	 of	 proper	 inhaler	
technique,	 medication	 adherence,	 control	 of	 environmental	
triggers	and	allergens,	and	smoking	cessation	is	also	beneficial	
for pregnant women.11
Uncontrolled	or	poorly	treated	diabetes	may	cause	spontaneous	
abortions,	 increased	 birth	 weight,	 still	 births,	 interuterine	
growth	 restrictions,	 and	 fetal	 abnormalities.12   The preferred 
anti-diabetic	 agent	 is	 insulin,	 since	 it	 does	 not	 cross	 the	
placenta.	 	 When	 used	 appropriately	 it	 maintains	 glycemic	
control and prevents hypoglycemia.  NPH is the preferred 
longer	 acting	 insulin.	 	 All	 short	 acting	 insulins,	 regular,	
lispro	 and	 aspart,	 are	 considered	 pregnancy	 category	 B	 by	
the	 Food	 and	 Drug	 Administration	 (FDA).	 	 Two	 oral	 agents	
that	 may	 be	 used	 especially	 if	 they	 were	 successful	 prior	 to	
pregnancy	are	metformin	and	glyburide.13   During pregnancy 
it	is	still	important	to	maintain	good	blood	glucose	levels	with	
appropriate	monitoring,	take	a	prenatal	vitamin	with	sufficient	
amount	of	folic	acid,	eat	foods	that	are	consistent	with	a	diabetic	
diet,	and	exercise	regularly.14
Depressed mothers may want to stop medications when they 
find	 out	 they	 are	 pregnant,	 but	 uncontrolled	 depression	may	
be	more	detrimental	to	the	fetus	than	medications’	side	effects.	
Risks	 to	 the	 mother	 include	 poor	 self-care	 and	 medication	
adherence,	suicidal	ideation,	illicit	drug	and	alcohol	usage,	low	
weight	 gain,	 postpartum	depression	 and	 self-injury	 behavior.	
Ramifications	to	the	fetus	are	premature	birth,	low	birth	weight,	
and admission to the neonatal intensive care unit upon delivery. 
Ultimately	the	child	may	have	delayed	cognitive	and	emotional	
development.6			When	choosing	an	antidepressant	always	assess	
the	risks	and	benefits	of	a	medication	prior	to	use	since	there	are	
no	efficacy	trials.	 	Caution	 is	warranted	with	paroxetine,	since	
the	FDA	classifies	 it	as	a	pregnancy	class	D.	 	 If	an	agent	needs	
to	be	started	during	pregnancy,	ideally	wait	until	after	the	first	
trimester	to	minimize	miscarriage	and	teratogenesis	risks.15,	16	
When	 treating	 pregnant	 women	 with	 chronic	 medical	
conditions,	always	treat	them	to	the	appropriate	goals	of	their	
condition	with	recommended	medications.	 	If	possible,	ensure	
counseling	 prior	 to	 conception	 so	 the	 patient	 knows	 what	
changes	should	be	made	for	the	safety	of	the	fetus	as	well	as	
the	mother.	 	With	medication	 therapy	weigh	 the	 risks	 of	 the	
medications’	side	effects	from	that	of	the	condition.		Treatment	
should	 also	 include	 non-pharmacologic	 therapy	 as	 well	 as	
regular patient monitoring to ensure a safe pregnancy.
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